E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/11/2016 in the Prospect News PIPE Daily.

Aytu registers $26.75 million of stock with warrants for public sale

The five-year warrant to be exercisable at 125% of the per-share price

By Devika Patel

Knoxville, Tenn., March 11 – Aytu BioScience, Inc. will price a public offering of common stock and warrants with a 45-day greenshoe, according to a Form S-1 filed Friday with the Securities and Exchange Commission. The company has registered up to $26.75 million of underlying stock for the deal.

Each five-year warrant will be exercisable at 125% of the per-share price.

Joseph Gunnar & Co. and Fordham Financial Management are the bookrunners.

Proceeds will be used for sales force expansion, clinical development, working capital and general corporate and administrative expenses.

The health care company is based in Englewood, Colo.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.